ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,285.34
0.47%
Dow Jones
38,859.83
0.14%
Gold vs US Dollar
2,372.445
0.74%
Brent Oil
79.875
1.67%
Bitcoin
71,154.97
0.11%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Corcept Therapeutics Inc (CORT)

  7. Corcept Therapeutics Inc (CORT) News

Corcept Therapeutics (CORT)

Corcept Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CORT
DateTimeSourceHeadlineSymbolCompany
06/06/202402:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
06/06/202402:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
06/06/202402:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
06/06/202402:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
06/06/202402:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
06/06/202402:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
03/06/202419:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
03/06/202419:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
03/06/202418:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
03/06/202413:00GlobeNewswire Inc.Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)NASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:47Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:46Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:45Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:43Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:41Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:40Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:39Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:38Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:38Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:38Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
31/05/202421:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CORTCorcept Therapeutics Inc
31/05/202402:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
31/05/202401:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
29/05/202400:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
28/05/202418:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
28/05/202418:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
28/05/202413:00GlobeNewswire Inc.Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)NASDAQ:CORTCorcept Therapeutics Inc
23/05/202421:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CORTCorcept Therapeutics Inc
21/05/202423:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CORT

Your Recent History

LSE
POS
Plexus
LSE
GGP
Greatland Gold
LSE
VAST
Vast Resources
LSE
SOLG
Solgold
LSE
GCM
Gcm Resources
LSE
RTOP
Regtech Open Project
LSE
GDR
Genedrive
LSE
VRS
Versarien
LSE
AGL
Angle
LSE
MIN
Minoan
LSE
TERN
Tern
LSE
JSE
Jadestone Energy
LSE
ITM
Itm Power
LSE
PANR
Pantheon Resources
LSE
KEFI
Kefi Gold And Copper
LSE
PFC
Petrofac
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved